SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2010, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Bethesda, MD: National Cancer Institute; 2013.
  • 2
    Green DM, Grigoriev YA, Nan B, et al. Congestive heart failure after treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 2001; 19:19261934.
  • 3
    Green DM, Grigoriev YA, Nan B, et al. Correction to “Congestive heart failure after treatment for Wilms' tumor”. J Clin Oncol 2003; 21:24472448.
  • 4
    Breslow NE, Lange JM, Friedman DL, et al. Secondary malignant neoplasms after Wilms tumor: An international collaborative study. Int J Cancer 2010; 127:657666.
  • 5
    Breslow NE, Takashima JR, Whitton JA, et al. Second malignant neoplasms following treatment for Wilm's tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 1995; 13:18511859.
  • 6
    Breslow NE, Norkool PA, Olshan A, et al. Second malignant neoplasms in survivors of Wilms' tumor: A report from the National Wilms' Tumor Study. J Natl Cancer Inst 1988; 80:592595.
  • 7
    Green DM, Peabody EM, Nan B, et al. Pregnancy outcome after treatment for Wilms tumor: A report from the National Wilms Tumor Study Group. J Clin Oncol 2002; 20:25062513.
  • 8
    Green DM, Lange JM, Peabody EM, et al. Pregnancy outcome after treatment for Wilms tumor: A report from the National Wilms Tumor Long-Term Follow-Up Study. J Clin Oncol 2010; 28:28242830.
  • 9
    Breslow NE, Collins AJ, Ritchey ML, et al. End stage renal disease in patients with Wilms tumor: Results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol 2005; 174:19721975.
  • 10
    Breslow NE, Takashima JR, Ritchey ML, et al. Renal failure in the Denys-Drash and Wilms' tumor-aniridia syndromes. Cancer Res 2000; 60:40304032.
  • 11
    Lange J, Peterson SM, Takashima JR, et al. Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor. J Urol 2011; 186:378386.
  • 12
    Ritchey ML, Green DM, Thomas PR, et al. Renal failure in Wilms' tumor patients: A report from the National Wilms' Tumor Study Group. Med Pediatr Oncol 1996; 26:7580.
  • 13
    Hostetter TH, Olson JL, Rennke HG, et al. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 1981; 241:F85F93.
  • 14
    Hostetter TH, Olson JL, Rennke HG, et al. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. J Am Soc Nephrol 2001; 12:13151325.
  • 15
    Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol 1985; 249:F324F337.
  • 16
    Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982; 307:652659.
  • 17
    Deen WM, Maddox DA, Robertson CR, et al. Dynamics of glomerular ultrafiltration in the rat. VII. Response to reduced renal mass. Am J Physiol 1974; 227:556562.
  • 18
    Anderson S, Meyer TW, Rennke HG, et al. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76:612619.
  • 19
    Kren S, Hostetter TH. The course of the remnant kidney model in mice. Kidney Int 1999; 56:333337.
  • 20
    Miller DC, Schonlau M, Litwin MS, et al. Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer 2008; 112:511520.
  • 21
    Ibrahim HN, Foley R, Tan L, et al. Long-term consequences of kidney donation. N Engl J Med 2009; 360:459469.
  • 22
    Morgan BR, Ibrahim HN. Long-term outcomes of kidney donors. Curr Opin Nephrol Hypertens 2011; 20:605609.
  • 23
    Segev DL, Muzaale AD, Caffo BS, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA 2010; 303:959966.
  • 24
    Lucas SM, Stern JM, Adibi M, et al. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 2008; 179:7579, discussion 79–80.
  • 25
    Coppes MJ, Arnold M, Beckwith JB, et al. Factors affecting the risk of contralateral Wilms tumor development: A report from the National Wilms Tumor Study Group. Cancer 1999; 85:16161625.
  • 26
    Beckwith JB, Kiviat NB, Bonadio JF. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 1990; 10:136.
  • 27
    Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 2009; 4:18321843.
  • 28
    Schwartz GJ, Furth S, Cole SR, et al. Glomerular filtration rate via plasma iohexol disappearance: Pilot study for chronic kidney disease in children. Kidney Int 2006; 69:20702077.
  • 29
    Blaufox MD, Aurell M, Bubeck B, et al. Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med 1996; 37:18831890.
  • 30
    Carlsen JE, Moller ML, Lund JO, et al. Comparison of four commercial Tc-99m(Sn)DTPA preparations used for the measurement of glomerular filtration rate: Concise communication. J Nucl Med 1980; 21:126129.
  • 31
    Jereb B, Aperia A, Berg U, et al. Renal function in long term survivors after treatment for nephroblastoma. Acta Paediatr Scand 1973; 62:577584.
  • 32
    Wikstad I, Pettersson BA, Elinder G, et al. A comparative study of size and function of the remnant kidney in patients nephrectomized in childhood for Wilms' tumor and hydronephrosis. Acta Paediatr Scand 1986; 75:408414.
  • 33
    Donckerwolcke RM, Coppes MJ. Adaptation of renal function after unilateral nephrectomy in children with renal tumors. Pediatr Nephrol 2001; 16:568574.
  • 34
    Srinivas M, Agarwala S, Padhy AK, et al. Somatic growth and renal function after unilateral nephrectomy for Wilms' tumor. Pediatr Surg Int 1998; 14:185188.
  • 35
    Bailey S, Roberts A, Brock C, et al. Nephrotoxicity in survivors of Wilms' tumours in the North of England. Br J Cancer 2002; 87:10921098.
  • 36
    Makipernaa A, Koskimies O, Jaaskelainen J, et al. Renal growth and function 11–28 years after treatment of Wilms' tumour. Eur J Pediatr 1991; 150:444447.
  • 37
    Levitt GA, Yeomans E, Dicks Mireaux C, et al. Renal size and function after cure of Wilms' tumour. Br J Cancer 1992; 66:877882.
  • 38
    de Graaf SS, van Gent H, Reitsma-Bierens WC, et al. Renal function after unilateral nephrectomy for Wilms' tumour: The influence of radiation therapy. Eur J Cancer 1996; 32A:465469.
  • 39
    Indolfi P, Di Tullio MT, Casale F, et al. Kidney size and function after unilateral nephrectomy for Wilms tumor: A longitudinal study. Med Pediatr Oncol 2001; 37:485486.
  • 40
    Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:3141.
  • 41
    Miller WG, Myers GL, Ashwood ER, et al. Creatinine measurement: State of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med 2005; 129:297304.
  • 42
    Schwartz GJ, Kwong T, Erway B, et al. Validation of creatinine assays utilizing HPLC and IDMS traceable standards in sera of children. Pediatr Nephrol 2009; 24:113119.
  • 43
    Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461470.
  • 44
    National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1S266.
  • 45
    Leger F, Bouissou F, Coulais Y, et al. Estimation of glomerular filtration rate in children. Pediatr Nephrol 2002; 17:903907.
  • 46
    Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145:247254 [Erratum appears in Ann Intern Med 2008 Oct 2007;2149(2007):2519].
  • 47
    Earley A, Miskulin D, Lamb EJ, et al. Estimating equations for glomerular filtration rate in the era of creatinine standardization: A systematic review. Ann Intern Med 2012; 156:785795.
  • 48
    Levey AS, Coresh J, Greene T, et al. Expressing the MDRD Study equation for estimating GFR with IDMS traceable (gold standard) serum creatinine values. J Am Soc Nephrol 2005; 16:69A [Abstract F-FC142].
  • 49
    Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604612 [Erratum appears in Ann Intern Med 2011 Sep 2020;2155(2016):2408].
  • 50
    Schwartz GJ, Haycock GB, Edelmann CMJ. A S. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58:259263.
  • 51
    Schwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 1985; 106:522526.
  • 52
    Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987; 34:571590.
  • 53
    Counahan R, Chantler C, Ghazali S, et al. Estimation of glomerular filtration rate from plasma creatinine concentration in children. Arch Dis Child 1976; 51:875878.
  • 54
    Zappitelli M, Joseph L, Gupta IR, et al. Validation of child serum creatinine-based prediction equations for glomerular filtration rate. Pediatr Nephrol 2007; 22:272281.
  • 55
    Thienpont LM, Leenheer AP, Stockl D, Reinauer H. Candidate reference methods for determining target values for cholesterol, creatinine, uric acid, and glucose in external quality assessment and internal accuracy control. II. Method transfer. Clin Chem 1993; 39:10011006.
  • 56
    Stockl D, Reinauer H. Candidate reference methods for determining target values for cholesterol, creatinine, uric acid, and glucose in external quality assessment and internal accuracy control. I. Method setup. Clin Chem 1993; 39:9931000.
  • 57
    Mattman A, Eintracht S, Mock T, et al. Estimating pediatric glomerular filtration rates in the era of chronic kidney disease staging. J Am Soc Nephrol 2006; 17:487496.
  • 58
    Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: A report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006; 52:518.
  • 59
    Rule AD, Glassock RJ. GFR estimating equations: Getting closer to the truth? Clin J Am Soc Nephrol 2013; 8:14141420.
  • 60
    Hogg RJ, Portman RJ, Milliner D, et al. Evaluation and management of proteinuria and nephrotic syndrome in children: Recommendations from a pediatric nephrology panel established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination (PARADE). Pediatrics 2000; 105:12421249.
  • 61
    Barrera M, Roy LP, Stevens M. Long-term follow-up after unilateral nephrectomy and radiotherapy for Wilms' tumour. Pediatr Nephrol 1989; 3:430432.
  • 62
    Mpofu C, Mann JR. Urinary protein/creatinine index in follow up of patients with Wilms' tumour after nephrectomy. Arch Dis Child 1992; 67:14621466.
  • 63
    Di Tullio MT, Casale F, Indolfi P, et al. Compensatory hypertrophy and progressive renal damage in children nephrectomized for Wilms' Tumor. Med Pediatr Oncol 1996; 26:325328.